TRANSITION SERVICES AGREEMENTTransition Services Agreement • November 8th, 2018 • Midatech Pharma PLC • Pharmaceutical preparations • Delaware
This Transition Services Agreement (this “Agreement”), effective as of November 1, 2018 (the “Effective Date”), is entered into by and between Midatech Pharma PLC, a company formed under the laws of England and Wales (“Provider”), Midatech Pharma US Inc., a Delaware corporation (“Company”), and Kanwa Holdings, LP, a Delaware limited partnership (“Purchaser,” and collectively with the Company, the “Purchaser Parties”). Capitalized terms used in this Agreement and not otherwise defined in this Agreement shall have the respective meanings ascribed to them in that certain Stock Purchase Agreement (the “Purchase Agreement”), dated as of September 26, 2018, by and among Purchaser, Provider and the Company.
